Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California. more
Time Frame | BCDA | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.49% | -3.39% | 0.2% |
1-Month Return | 2.43% | -1.92% | 2.72% |
3-Month Return | -24.73% | -10.54% | 7.31% |
6-Month Return | -37.13% | -4.47% | 10.44% |
1-Year Return | -78.5% | 4.06% | 27.53% |
3-Year Return | -92% | 0.94% | 30.88% |
5-Year Return | -96.27% | 36.67% | 89.21% |
10-Year Return | -98.71% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 710.00K | 145.00K | 1.01M | 1.35M | 477.00K | [{"date":"2019-12-31","value":52.51,"profit":true},{"date":"2020-12-31","value":10.72,"profit":true},{"date":"2021-12-31","value":75.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.28,"profit":true}] |
Cost of Revenue | 358.00K | 4.00K | 640.00K | 11.90M | 7.73M | [{"date":"2019-12-31","value":3.01,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":5.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.92,"profit":true}] |
Gross Profit | 352.00K | 141.00K | 375.00K | (10.55M) | (7.25M) | [{"date":"2019-12-31","value":93.87,"profit":true},{"date":"2020-12-31","value":37.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2813.07,"profit":false},{"date":"2023-12-31","value":-1933.07,"profit":false}] |
Gross Margin | 49.58% | 97.24% | 36.95% | (780.25%) | (1519.71%) | [{"date":"2019-12-31","value":50.98,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":37.99,"profit":true},{"date":"2022-12-31","value":-802.39,"profit":false},{"date":"2023-12-31","value":-1562.82,"profit":false}] |
Operating Expenses | 14.56M | 15.67M | 13.64M | 13.25M | 12.12M | [{"date":"2019-12-31","value":92.95,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.08,"profit":true},{"date":"2022-12-31","value":84.58,"profit":true},{"date":"2023-12-31","value":77.35,"profit":true}] |
Operating Income | (14.21M) | (15.53M) | (12.63M) | (11.90M) | (11.64M) | [{"date":"2019-12-31","value":-1421300000,"profit":false},{"date":"2020-12-31","value":-1552900000,"profit":false},{"date":"2021-12-31","value":-1263000000,"profit":false},{"date":"2022-12-31","value":-1190100000,"profit":false},{"date":"2023-12-31","value":-1164400000,"profit":false}] |
Total Non-Operating Income/Expense | (521.00K) | 543.00K | 16.00K | - | - | [{"date":"2019-12-31","value":-95.95,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.95,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (14.71M) | (15.00M) | (12.62M) | (11.91M) | (11.57M) | [{"date":"2019-12-31","value":-1470900000,"profit":false},{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}] |
Income Taxes | 110.00K | 1.00K | (2.00K) | 6.00K | 243.10K | [{"date":"2019-12-31","value":45.25,"profit":true},{"date":"2020-12-31","value":0.41,"profit":true},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":2.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (14.82M) | (15.01M) | (12.62M) | - | - | [{"date":"2019-12-31","value":-1481900000,"profit":false},{"date":"2020-12-31","value":-1500500000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (14.71M) | (15.00M) | (12.62M) | (11.91M) | (11.57M) | [{"date":"2019-12-31","value":-1470900000,"profit":false},{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.82M) | (15.01M) | (12.62M) | (11.91M) | (11.57M) | [{"date":"2019-12-31","value":-1481900000,"profit":false},{"date":"2020-12-31","value":-1500500000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":-1191300000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}] |
EPS (Diluted) | (2.73) | (1.39) | (0.74) | (0.67) | (0.55) | [{"date":"2019-12-31","value":-273,"profit":false},{"date":"2020-12-31","value":-139,"profit":false},{"date":"2021-12-31","value":-74,"profit":false},{"date":"2022-12-31","value":-67,"profit":false},{"date":"2023-12-31","value":-55,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BCDA | |
---|---|
Cash Ratio | 1.74 |
Current Ratio | 1.78 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BCDA | |
---|---|
ROA (LTM) | -115.93% |
ROE (LTM) | -703.62% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BCDA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.56 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BCDA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 22.49 |
P/B | 3.50 |
Price/FCF | NM |
EV/R | 80.87 |
EV/Ebitda | NM |
PEG | NM |
Biocardia Inc (BCDA) share price today is $2.045
Yes, Indians can buy shares of Biocardia Inc (BCDA) on Vested. To buy Biocardia Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Biocardia Inc (BCDA) via the Vested app. You can start investing in Biocardia Inc (BCDA) with a minimum investment of $1.
You can invest in shares of Biocardia Inc (BCDA) via Vested in three simple steps:
The 52-week high price of Biocardia Inc (BCDA) is $10.79. The 52-week low price of Biocardia Inc (BCDA) is $1.84.
The price-to-earnings (P/E) ratio of Biocardia Inc (BCDA) is
The price-to-book (P/B) ratio of Biocardia Inc (BCDA) is 3.50
The dividend yield of Biocardia Inc (BCDA) is 0.00%
The market capitalization of Biocardia Inc (BCDA) is $9.63M
The stock symbol (or ticker) of Biocardia Inc is BCDA